Coverage
-
March 29, 2013
A California federal judge Thursday brought closer to an end Allergan Inc.'s long-running patent infringement and false advertising suit over its eyelash-enhancing drug Latisse after the company inked a deal that dropped competition and noninfringement claims by three rivals.
2 other articles on this case.
View all »